You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

November 22, 2018

Clearing the Air on Cannabis Patents

Bangkok Post

The patent system has become an unlikely hot topic in Thailand in light of reports that some overseas pharmaceutical companies have applied for Thai patents for cannabis. The revelations have added more fuel to the ongoing debate about the utility of cannabis, a Thai local plant. The reports have led many to criticize the patent system, questioning whether patent rights may obstruct Thai researchers’ studies on cannabis. It is important not to oversimplify this issue. Such dialogue is extremely important and must be encouraged, but as a patent attorney I find the broader context of the patent system very enlightening in understanding the arguments on both sides.

The most important context of course is the reasoning behind the patent system in the first place. An internationally accepted rationale for patent law is that a patent grants security to an inventor who, through his or her intellect and labor, has conceived an invention that benefits the society. Granting that inventor patent rights prevents others from exploiting the fruit of that inventor’s labor without consent. Simply put, patents prevent anyone from stealing an inventor’s idea. In exchange, the inventor has a duty to make the details (or the “secret trick”) of his or her invention available to the public through the process of patent application. Importantly, a patent is in force for no more than 20 years, after which the knowledge in that patent will become public information for anyone’s free use.

With that in mind, we can begin to look at the specific context of cannabis-based patents.

 

The patent system has become an unlikely hot topic in Thailand in light of reports that some overseas pharmaceutical companies have applied for Thai patents for cannabis. The revelations have added more fuel to the ongoing debate about the utility of cannabis, a Thai local plant. The reports have led many to criticize the patent system, questioning whether patent rights may obstruct Thai researchers’ studies on cannabis. It is important not to oversimplify this issue. Such dialogue is extremely important and must be encouraged, but as a patent attorney I find the broader context of the patent system very enlightening in understanding the arguments on both sides.

The most important context of course is the reasoning behind the patent system in the first place. An internationally accepted rationale for patent law is that a patent grants security to an inventor who, through his or her intellect and labor, has conceived an invention that benefits the society. Granting that inventor patent rights prevents others from exploiting the fruit of that inventor’s labor without consent. Simply put, patents prevent anyone from stealing an inventor’s idea. In exchange, the inventor has a duty to make the details (or the “secret trick”) of his or her invention available to the public through the process of patent application. Importantly, a patent is in force for no more than 20 years, after which the knowledge in that patent will become public information for anyone’s free use.

With that in mind, we can begin to look at the specific context of cannabis-based patents.

Current State of Cannabis Patents in Thailand

A preliminary investigation into the Department of Intellectual Property (DIP) database shows that 91 patent applications have been filed in Thailand relating to the group of chemicals found in cannabis. This search excludes any incidental uses such as traditional medicines and textile industry applications. Among these, only one application has been registered as a Thai patent, and that patent was later revoked. Of the remaining 90 applications, 51 were abandoned without registration. The remaining 39 have been published and are pending substantial examination by the DIP.

It is important to clarify that a patent application is not the same as patent registration. Rights do not exist until an application is registered, and before registration the applicant has no right to sue anyone. Therefore, no one, Thai or foreign, is currently able to sue anyone for infringing a cannabis extract patent in Thailand.

Natural Substances

One hotly debated point is whether or not people should be able to patent “natural substances.” This is an odd argument from a patent attorney’s point of view, because the law already addresses it. Section 9 (1) of the Thai Patent Act B.E. 2522 (1979) expressly prevents “animals, plants or extracts from animals or plants” from being patented. The next logical step is to dig deeper into what that actually means.

The DIP’s Patent Examination Guideline B.E. 2555 (2012), section 1, part 1, page 28, explains that unpatentable “animals, plants or extracts from animals or plants” includes “higher animals and higher plants that are available in nature” and “extracts from animals or plants that have not undergone any man-made substantial processing” (emphasis added). The underlying reason is that a protectable invention must owe its existence to human’s intelligence. The existence of plants, animals, or other things that exist in nature may not be claimed by a human. In cannabis’ case, this law means that the cannabis plant, including its stem, flower, leaf, and crude extracts are not patentable. 

On the other hand, if a human brings a natural thing to be processed by technical means, and thereby causes results and benefits that are not found in the natural state of that thing, then that processed natural thing may be patented. For example, suppose that a certain plant contains Substance A which, in its natural state, does not exhibit any therapeutic effects. Suppose that a researcher later found a way to transform Substance A, or make a pharmaceutical formula containing Substance A, which enables Substance A to perform as an active ingredient for effective treatment of hypertension. The method for transforming that substance, or the pharmaceutical formula, is an invention which may be lawfully patented.

Section 9 (1) must be interpreted with care, and in the proper context of the rationale for patent law, to avoid it leading to slippery slope arguments that negatively affect the patent system. It is true that all human inventions can be traced back to products of nature. For example, many polymers are derived from crude oil, which is found in nature. However, a new petroleum-based polymer that is stronger than steel should be patentable, despite being developed from a product of nature. If Section 9 (1) is interpreted to mean that anything related to nature in any way cannot be patented, then nothing would be patentable.

Preventing the Obstruction of Research

Another hotly debated issue surrounding cannabis patents is a concern that Thai patent registration (which has yet to occur, as noted above) may obstruct medical cannabis research by Thai researchers. This is a rather unlikely scenario for two extremely important reasons.

Firstly, patent protection has a limited scope. Using the Substance A example above, suppose that a patent has been issued for the use of Substance A as a treatment for hypertension (and that the patent has passed all other provisions of the Patent Act). That patent will only cover the use of Substance A for the reasons, and by the means, specified in the patent. The patentee has no right to prevent others from using Substance A for other purposes, for treating other illnesses, or for treating hypertension by a means that is substantially different from what is specified in the patent. In addition, since the patent claims for the “use,” not for Substance A itself (which cannot be patented, as noted above), the patentee is not entitled to prevent others from using or handling Substance A in any other way.

Secondly, research and study are not patent infringement. Section 36, paragraph 2, subsection 1 of the Patent Act provides that “any act for the purpose of study, research, experimentation or analysis” does not infringe upon any patent. This means any study or research that does not compete with the patentee’s business, such as a research conducted by a professor in a medical school, will not expose the researcher to any liability.

The Usefulness of Patents

Finally, in considering these matters in the broader context, it is important to be aware of the general usefulness of the patent system in a broader sense. The patenting system is important for the modern economy. It incentivizes research and development activities, and it allows for knowledge transfer for the public benefit. Patent applications must disclose clear and detailed information about the invention that they relate to, making the complete details of an invention publicly available, from which new ideas and further developments will arise. Researchers are free to study the patents and then seek a technical improvement, which may be patentable in its own right. In addition, when the patent has expired (no longer than 20 years), the once-patented invention will become public knowledge available for anyone’s free use.

The case of cannabis patents is a great opportunity for the Thai public to converse, debate, and consider the benefits and shortcomings of the current patent law system, and hopefully to provide critiques for the betterment of our patent law. However, it is important for any such critique to have a good understanding of the facts on both sides of the argument, before a thorough analysis can take place.

RELATED INSIGHTS​ 

August 4, 2026
Intellectual property (IP) protection sometimes hinges on fame and recognition. However, this alone will not always be sufficient to overcome an IP dispute when it involves contractual obligations or registered rights. Below are five cases from around the world that tackle some of the basic issues in IP registration, ownership, commercialization, and enforcement. 1. USA: Taylor Swift Trademark Application Refused Taylor Swift recently filed a trademark application to register “The Life of a Showgirl,” which is the title of her 12th studio album. When examining a trademark application, the examiner considers various factors before deciding whether it should be registered. One of these factors is whether there is a likelihood of confusion (i.e., would a regular consumer mistake the origin of the trademark). In Taylor Swift’s case, the US Patent and Trademark Office (USPTO) decided that that there would be a risk of confusion. This decision was based on the existing registered trademark, “Confessions of a Showgirl,” owned by Maren Wade, which was registered in 2015. The USPTO refused Taylor Swift’s application based on the shared key distinctive element “of a showgirl,” the lack of sufficient distinguishing terms, the marks being used in overlapping markets (entertainment and performances), and because consumers may assume a common commercial source. Maren Wade then filed a lawsuit in California against Taylor Swift and her affiliated companies, arguing that Taylor Swfit’s branding is confusingly similar in structure, wording, and overall commercial impression to her registered mark. She is also drawing on the USPTO’s refusal of Taylor Swift’s application to support her argument of a likelihood of confusion. A judgment has not yet been reached in this case, but it serves as an important reminder of the importance of satisfying the essential elements required for IP registration. 2. Australia: Katy Perry v. Katie Perry In
July 27, 2026
Vietnam’s new E-Commerce Law, which took effect on 1 July 2026 along with its implementing Decree No. 248/2026/ND-CP (Decree 248), marks a significant development in the country’s approach to online intellectual property (IP) enforcement, reflecting a clear shift from a reactive model of intermediary liability to one that expects platforms to play a more active role in preventing infringement. From notice-and-takedown to platform responsibility The most significant change introduced by the E-Commerce Law is the transformation of the legal role of e-commerce platforms. The existing safe harbor provisions under the IP Law and the copyright notice-and-takedown regime established by Decree 17/2023/ND-CP (Decree 17) largely required intermediaries to act only after receiving notice of infringement. Once infringing content had been removed, the platform’s legal obligation was generally considered fulfilled. The new legislation adopts a fundamentally different approach. Article 17 of the E-Commerce Law requires intermediary platforms to screen information relating to goods and services before publication in order to prevent listings involving counterfeit or IP-infringing goods, and goods of unknown origin. Rather than relying exclusively on complaints from rights holders, platforms are now expected to implement preventive measures before infringing listings become publicly available. Decree 248 further requires platforms to update keyword filters based on recommendations issued by competent authorities. These filtering mechanisms are intended to prevent prohibited listings from appearing on the platform and represent a further move away from a purely complaint-driven enforcement model. The legislation also introduces Vietnam’s first statutory stay-down obligation. Under the E-Commerce Law and Decree 248, major digital platforms must maintain automated systems capable of reviewing, warning against, and removing unlawful listings while also implementing measures to prevent repeat violations, defined under Decree 248 as conduct that has previously been identified and handled by the platform, but continues to recur. This obligation addresses one
July 27, 2026
Tilleke & Gibbins’ intellectual property specialists have authored the Thailand chapter of Trade Secrets 2026 from Chambers and Partners. This global guide examines the legal frameworks governing trade secret protection, enforcement, and litigation across jurisdictions worldwide. The Thailand chapter provides a comprehensive overview of the country’s legal regime for protecting confidential business information, covering the legal framework, trade secret misappropriation, litigation procedures, remedies, and dispute resolution. Some topics covered include: Protectable trade secrets Reasonable measures to maintain secrecy Employee confidentiality Trade secret licensing Civil and criminal remedies Litigation procedures and injunctions Damages and other remedies Mediation and arbitration The guide also examines practical issues relating to safeguarding trade secrets, defending against allegations of misappropriation, and managing trade secret disputes in Thailand. Chambers and Partners’ Global Practice Guides provide in-house counsel with authoritative commentary on practical legal issues affecting business, enabling readers to compare legislation and procedures across multiple jurisdictions. The Thailand chapter of Trade Secrets 2026 is available as a PDF through the button below. The full guide can be accessed for free on the Chambers and Partners website.
July 27, 2026
In March 2025, Thailand’s Central Intellectual Property and International Trade Court (IP&IT Court) issued a landmark judgment in favor of Luckin Coffee, China’s leading retail coffee chain. The judgment marked a significant turnaround following earlier trademark litigation involving Luckin Coffee from 2021 to 2023 that had generated widespread public attention and raised questions about the protection available to legitimate foreign brand owners in Thailand. In a significant subsequent development, Thailand’s Court of Appeal for Specialized Cases has now affirmed the IP&IT Court’s judgment in its entirety. The appellate decision brings clarity to one of Thailand’s most closely watched trademark disputes. Significantly, this is the first case in Thailand to formally recognize the trademark squatting principle. The Court of Appeal confirmed that Luckin Coffee has a better right to the disputed mark and ordered cancellation of the defendants’ trademark registration—a key application of the “better right” doctrine. The court also upheld the substantial damages awarded at first instance, providing important guidance on assessing harm from systematic trademark squatting. Award-Winning Judgment Affirmed in Its Entirety The significance of the first-instance judgment extended beyond the outcome for Luckin Coffee. The IP&IT Court judgment was subsequently recognized in the IP&IT Court’s Distinguished Judgment Awards in 2025, reflecting the complexity, novelty, and legal significance of the issues considered in the case. The defendants nevertheless appealed the judgment, challenging several key aspects of the IP&IT Court’s decision. Luckin Coffee continued to entrust Tilleke & Gibbins as their sole attorney to pursue the case at the appellate level. After considering the defendants’ appeal and Luckin Coffee’s submissions in response, the Court of Appeal affirmed the first-instance judgment in its entirety. The judgment was announced on July 8, 2026. Better Right to the Marks The Court of Appeal confirmed Luckin Coffee’s superior rights. The orders include cancellation